《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2014年 > 11期

 新诊断2型糖尿病患者胰岛素泵强化治疗血糖长期缓解的效果及影响因素分析

来自:中国糖尿病杂志  编辑: 岳建美 井庆平|点击数:|2014-11-24

•糖尿病胰岛素治疗·

  【摘要】 目的 观察新诊断T2DM患者短期胰岛素强化降糖治疗后影响血糖长期缓解的因素。 方法 选取新诊断T2DM患者32例胰岛素泵治疗2周,测定治疗前后OGTT 0.5 h、1 h、2 hPG及Ins,计算胰岛β细胞功能(HOMA-β)、胰岛素抵抗指数(HOMA-IR)和第一时相胰岛素分泌(ΔI30/ΔG30)。观察3年后血糖缓解情况,分析影响因素。 结果 胰岛素泵强化治疗后,FPG、0.5 hPG、2 hPG、HOMA-IR均较治疗前下降,HOMA-β和ΔI30/ΔG30升高(P<0.01)。3年后血糖缓解率为28.1%(9/32)。Logistic回归分析显示,强化治疗后有氧运动是血糖长期缓解的重要因素(OR=24,P<0.05)。 结论 新诊断T2DM患者短期胰岛素泵强化治疗可长期缓解血糖,有氧运动是血糖长期缓解的重要因素。

  【关键词】 糖尿病,2型;持续胰岛素皮下输注;有氧运动

  【Abstract】 Objective To observe the effect of long-term glycemic control of insulin pump for therapy on newly diagnosed type 2 diabetic patients and its influencing factors. Methods 32 patients with newly diagnosed type 2 diabetes were treated with continuous subcutaneous insulin infusion (CSII) therapy for 2 weeks. OGTT 0.5 h、1 h、2 hPG and Ins were measured, and HOMA-β, HOMA-IR, and early-stage insulin secretion index(ΔI30/ΔG30) were calculated before and after treatment. Patients who maintained glycemic control for 3 years were defined as remission while those who failed to maintain glycemic control as hyperglycemia relapse. Results After CSII, the level of FPG、0.5 hPG、2 hPG、HOMA-IR was lower after treatment than before treatment, but HOMA-β and ΔI30/ΔG30 was higher(P<0.01). The remission rate of blood glucose was 28.1%(9/32). Logistic regression analyses showed that aerobic exercise after CSII was independent predictor of long term euglycemia remission (OR=24, P<0.05). Conclusion Newly diagnosed T2DM patients with short-term insulin pump intensive therapy can relieve blood glucose for a long time, aerobic exercise after CSII is a convenient and significant predictor for long term euglycemia remission.

  【Key words】 Diabetes mellitus, type 2;Continuous subcutaneous insulin infusion;Aerobic exercise

上一篇:  胰岛素治疗2型糖尿病的优化方案及其相关因素分析 下一篇: 胰岛素泵持续皮下注射治疗儿童1型糖尿病疗效及安全性的观察